Acinetobacter sp. VT-511, Isolated from the Stomach of a Patient with Gastric Cancer
It has become clear that microorganisms contribute to the development and progression of oncogenesis. Therefore, the isolation of novel bacteria directly from the site of oncological processes is of primary interest. We recently isolated one such bacterium, Acinetobacter sp. VT-511. This organism comprises a novel species of Acinetobacter that was isolated from the stomach of a patient with gastric cancer. Genetic analyses revealed that the organism encodes gene sequences predicted to encode macrolide-specific efflux proteins and ABC, MATE, and RND family multidrug resistance transporters. In addition, the organism harbors genes that would provide resistance to ethidium bromide, fluoroquinolones, macrolides, fosmidomycin, and bacteriocin, as well as genes encoding virulence factors such as adhesins, polysaccharides, peptidases, and proteases.
Tetz, G., & Tetz, V. (2015). Draft Genome Sequence of Acinetobacter sp. strain VT-511 Isolated from the Stomach of a Patient with Gastric Cancer. Genome Announcements, 3(5), e01202-15.